Multimodal treatment strategies in Huntington’s disease
Open Access
- 15 July 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Neuroscience and Neurological Disorders
- Vol. 5 (2), 072-082
- https://doi.org/10.29328/journal.jnnd.1001054
Abstract
Huntington’s disease (HD) is an incurable neurodegenerative disease that causes involuntary movements, emotional lability, and cognitive dysfunction. HD symptoms usually develop between ages 30 and 50, but can appear as early as 2 or as late as 80 years. Currently no neuroprotective and neurorestorative interventions are available. Early multimodal intervention in HD is only possible if the genetic diagnosis is made early. Early intervention in HD is only possible if genetic diagnosis is made at the disease onset or when mild symptoms manifest. Growing evidence and understanding of HD pathomechanism has led researchers to new therapeutic targets. Here, in this article we will talk about the multimodal treatment strategies and recent advances made in this field which can be used to target the HD pathogenesis at its most proximal level.Keywords
This publication has 109 references indexed in Scilit:
- Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathwayCell Death & Disease, 2013
- The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse ModelsCell Reports, 2012
- Protein aggregates in Huntington's diseaseExperimental Neurology, 2012
- Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 miceProceedings of the National Academy of Sciences of the United States of America, 2012
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's DiseaseMolecular Therapy, 2011
- Protective effects and mechanisms of sirtuins in the nervous systemProgress in Neurobiology, 2011
- SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisProceedings of the National Academy of Sciences of the United States of America, 2010
- Zinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease MiceMolecular Therapy, 2009
- Acetylation Targets Mutant Huntingtin to Autophagosomes for DegradationCell, 2009